Clarity Pharmaceuticals Ltd (CU6) — Financial Flexibility Index
Clarity Pharmaceuticals Ltd (CU6) has a Financial Flexibility Index of -2.08x as of December 2025. Free cash flow of AU$-47.54 Million (operating CF AU$-47.79 Million minus capex AU$257.84K) represents -2% of total liabilities (AU$22.86 Million). Check CU6 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clarity Pharmaceuticals Ltd Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Clarity Pharmaceuticals Ltd across 8 annual periods. See Clarity Pharmaceuticals Ltd (CU6) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Clarity Pharmaceuticals Ltd (2018–2025)
Year-by-year free cash flow to debt coverage for Clarity Pharmaceuticals Ltd. For the full company profile including market capitalisation, see CU6 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.99x | AU$-54.59 Million | AU$-54.77 Million | AU$10.94 Million | ▲ +2.7% |
| 2024 | -5.13x | AU$-42.73 Million | AU$-43.24 Million | AU$8.33 Million | ▼ -44.2% |
| 2023 | -3.56x | AU$-27.45 Million | AU$-27.50 Million | AU$7.72 Million | ▼ -105.9% |
| 2022 | -1.73x | AU$-13.10 Million | AU$-13.31 Million | AU$7.59 Million | ▲ +47.0% |
| 2021 | -3.26x | AU$-7.62 Million | AU$-7.68 Million | AU$2.34 Million | ▲ +54.2% |
| 2020 | -7.13x | AU$-6.82 Million | AU$-6.83 Million | AU$956.09K | ▼ -119.5% |
| 2019 | -3.25x | AU$-3.69 Million | AU$-3.71 Million | AU$1.14 Million | ▼ -86.3% |
| 2018 | -1.74x | AU$-1.49 Million | AU$-1.50 Million | AU$857.04K | — |